HTG Molecular Diagnostics to Announce Second Quarter 2021 Financial Results and Host Conference Call on Thursday, August 12
HTG Molecular Diagnostics (HTGM) announced it will release its financial results for Q2 2021 on August 12, 2021, after market close.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
HTG Molecular Diagnostics (HTGM) announced it will release its financial results for Q2 2021 on August 12, 2021, after market close. A conference call with investors is scheduled for 4:30 PM ET on the same day, aimed at discussing the financial outcomes and corporate updates. HTG is dedicated to advancing precision medicine through its proprietary HTG EdgeSeq technology, which enables complex molecular profiling from limited samples.
Positive
- Scheduled release of Q2 2021 financial results may provide insights into company performance.
- Focus on precision medicine aligns with current healthcare trends.
Negative
- None.
Details
News Market Reaction – HTGM
The recorded move for HTGM in the trading session of this news was -1.42%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
TUCSON, Ariz., Aug. 03, 2021 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM), a life science company whose mission is to advance precision medicine, today announced that it will report its financial results for the second quarter ended June 30, 2021 after the market close on Thursday, August 12, 2021. Management will also host a conference call with investors to discuss financial results and provide a corporate update at 4:30 pm ET.
| Conference Call & Webcast Details | |
| Date: | Thursday, August 12 |
| Time: | 4:30 pm ET |
| Toll Free: | 877-407-0789 |
| International: | 201-689-8562 |
| Conference ID: | 13721188 |
| Webcast: | http://public.viavid.com/index.php?id=145556 |
About HTG
HTG is focused on NGS-based molecular profiling. The company’s proprietary HTG EdgeSeq technology automates complex, highly multiplexed molecular profiling from solid and liquid samples, even when limited in amount. HTG’s customers use its technology to identify biomarkers important for precision medicine, to understand the clinical relevance of these discoveries, and ultimately to identify treatment options. Its mission is to empower precision medicine.
Contact:
Ashley R. Robinson
LifeSci Advisors, LLC
Phone: (617) 430-7577
Email: arr@lifesciadvisors.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.